Nonviral delivery of synthetic siRNAs in vivo

被引:389
作者
Akhtar, Saghir
Benter, Ibrahim F.
机构
[1] Kuwait Univ, Hlth Sci Ctr, Fac Med, Dept Pharmacol & Toxicol, Safat 13110, Kuwait
[2] SA Pharma, Sutton Coldfield, W Midlands, England
关键词
D O I
10.1172/JCI33494
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Sequence-specific gene silencing using small interfering RNA (siRNA) is a Nobel prize-winning technology that is now being evaluated in clinical trials as a potentially novel therapeutic strategy. This article provides an overview of the major pharmaceutical challenges facing siRNA therapeutics, focusing on the delivery strategies for synthetic siRNA duplexes in vivo, as this remains one of the most important issues to be resolved. This article also highlights the importance of understanding the genocompatibility/toxicogenomics of siRNA delivery reagents in terms of their impact on gene-silencing activity and specificity. Collectively, this information is essential for the selection of optimally acting siRNA delivery system combinations for the many proposed applications of RNA interference.
引用
收藏
页码:3623 / 3632
页数:10
相关论文
共 123 条
[41]   The cellular delivery of antisense oligonucleotides and ribozymes [J].
Hughes, MD ;
Hussain, M ;
Nawaz, Q ;
Sayyed, P ;
Akhtar, S .
DRUG DISCOVERY TODAY, 2001, 6 (06) :303-315
[42]   PEGylated liposomes elicit an anti-PEG IgM response in a T cell-independent manner [J].
Ishida, Tatsuhiro ;
Wang, Xinyu ;
Shimizu, Taro ;
Nawata, Kosuke ;
Kiwada, Hiroshi .
JOURNAL OF CONTROLLED RELEASE, 2007, 122 (03) :349-355
[43]   Exploiting the enhanced permeability and retention effect for tumor targeting [J].
Iyer, Arun K. ;
Khaled, Greish ;
Fang, Jun ;
Maeda, Hiroshi .
DRUG DISCOVERY TODAY, 2006, 11 (17-18) :812-818
[44]   Widespread siRNA "off-target'' transcript silencing mediated by seed region sequence complementarity [J].
Jackson, Aimee L. ;
Burchard, Julja ;
Schelter, Janell ;
Chau, B. Nelson ;
Cleary, Michele ;
Lim, Lee ;
Linsley, Peter S. .
RNA, 2006, 12 (07) :1179-1187
[45]   Expression profiling reveals off-target gene regulation by RNAi [J].
Jackson, AL ;
Bartz, SR ;
Schelter, J ;
Kobayashi, SV ;
Burchard, J ;
Mao, M ;
Li, B ;
Cavet, G ;
Linsley, PS .
NATURE BIOTECHNOLOGY, 2003, 21 (06) :635-637
[46]   Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA [J].
Judge, AD ;
Sood, V ;
Shaw, JR ;
Fang, D ;
McClintock, K ;
MacLachlan, I .
NATURE BIOTECHNOLOGY, 2005, 23 (04) :457-462
[47]   Intracellular delivery of oligonucleotide conjugates and dendrimer complexes [J].
Juliano, R. L. .
OLIGONUCLEOTIDE THERAPEUTICS, 2006, 1082 :18-26
[48]   Polymer genomics: An insight into pharmacology and toxicology of nanomedicines [J].
Kabanov, Alexander V. .
ADVANCED DRUG DELIVERY REVIEWS, 2006, 58 (15) :1597-1621
[49]   Tat-conjugated PAMAM dendrimers as delivery agents for antisense and siRNA oligonucleotides [J].
Kang, HM ;
DeLong, R ;
Fisher, MH ;
Juliano, RL .
PHARMACEUTICAL RESEARCH, 2005, 22 (12) :2099-2106
[50]   Targeted delivery systems of small interfering RNA by systemic administration [J].
Kawakami, Shigeru ;
Hashida, Mitsuru .
DRUG METABOLISM AND PHARMACOKINETICS, 2007, 22 (03) :142-151